Evidence map›Paper›PMID 35907878›Full record

ArticlePediatric rheumatology online journal2022

Bilateral anterior and intermediate uveitis in SARS-CoV-2 associated multisystem inflammatory syndrome in a pediatric patient.

Jessica Shantha, Amit K Reddy, Amol Sura, Adrian Tsang, Kareem Moussa, Nisha Acharya, John Gonzales, Thuy Doan

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Pediatric rheumatology online journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Jessica ShanthaFrancis I. Proctor Foundation, Department of Ophthalmology, University of California San Francisco, 490 Illinois Street, CA, 94158, San Francisco, USA. jessica.shantha@ucsf.edu.ORCID http://orcid.org/0000-0002-4449-8598
Amit K ReddyDepartment of Ophthalmology, University of Colorado School of Medicine, 1675 North Aurora Court F731, CO, 80045, Aurora, USA.
Amol SuraDepartment of Ophthalmology, Duke University, 2351 Erwin Rd, NC, 27705- 4699, Durham, USA.
Adrian TsangFrancis I. Proctor Foundation, Department of Ophthalmology, University of California San Francisco, 490 Illinois Street, CA, 94158, San Francisco, USA.
Kareem MoussaDavis Department of Ophthalmology & Vision Science, University of California, 4860 Y Street, Suite 2400, 490 Illinois Street, Floor 2, CA, 95817, 94158, Sacramento, San Francisco, USA.
Nisha AcharyaFrancis I. Proctor Foundation, Department of Ophthalmology, University of California San Francisco, 490 Illinois Street, CA, 94158, San Francisco, USA.
John GonzalesFrancis I. Proctor Foundation, Department of Ophthalmology, University of California San Francisco, 490 Illinois Street, CA, 94158, San Francisco, USA.
Thuy DoanFrancis I. Proctor Foundation, Department of Ophthalmology, University of California San Francisco, 490 Illinois Street, CA, 94158, San Francisco, USA.
University of California, San Francisco · USDuke University · USUniversity of California, Davis · USUniversity of Colorado Denver · US

Funding

NEI NIH HHS K-23EY030159
6 · The paper itself

Abstract

purposeTo report a case of bilateral anterior intermediate uveitis after recovery from SARS-CoV-2 associated multisystem inflammatory syndrome in children (MIS-C). CASE REPORT: A 9-year-old male presented with bilateral anterior intermediate uveitis with fluorescein angiography (FA) leakage of the disc and peripheral vasculature 1 month after recovery from MIS-C. He was treated with difluprednate 0.05% in both eyes with resolution of FA leakage, but our patient has required an extended treatment of topical therapy and the need long term immunosuppression.

conclusionsThis is a case of uveitis presenting after recent MIS-C related to SARS-CoV-2. Ongoing follow up and monitoring is required, and it is important for the ophthalmologist and rheumatologist to be aware of this rare complication during the current COVID-19 pandemic.

Indexed as

COVID-19UveitisUveitis, IntermediateChildHumansMalePandemicsSARS-CoV-2Systemic Inflammatory Response SyndromeCOVID-19Multisystem inflammatory syndrome in childrenUveitis

Identifiers

PMID35907878
PMCPMC9338464
OpenAlexW4288748613

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.